Ipatasertib Improves PFS in Advanced Triple-Negative Breast Cancer

The AKT inhibitor ipatasertib offered improved progression-free survival over placebo when combined with paclitaxel in women with triple-negative breast cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Breast Cancer News Triple-Negative Breast Cancer Source Type: news